Susquehanna International Group’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-25,400
| Closed | -$137K | – | 12538 |
|
|
2025
Q3 | $137K | Sell |
25,400
-210,700
| -89% | -$1.14M | ﹤0.01% | 11355 |
|
|
2025
Q2 | $1.28M | Buy |
236,100
+201,100
| +575% | +$798K | ﹤0.01% | 6807 |
|
|
2025
Q1 | $97K | Buy |
35,000
+100
| +0.3% | +$348 | ﹤0.01% | 11560 |
|
|
2024
Q4 | $119K | Sell |
34,900
-95,800
| -73% | -$276K | ﹤0.01% | 11198 |
|
|
2024
Q3 | $384K | Buy |
130,700
+39,000
| +43% | +$128K | ﹤0.01% | 9077 |
|
|
2024
Q2 | $312K | Buy |
+91,700
| New | +$300K | ﹤0.01% | 9357 |
|
|
2023
Q3 | – | Sell |
-44,200
| Closed | -$461K | – | 12142 |
|
|
2023
Q2 | $461K | Sell |
44,200
-26,500
| -37% | -$237K | ﹤0.01% | 8517 |
|
|
2023
Q1 | $493K | Sell |
70,700
-49,900
| -41% | -$435K | ﹤0.01% | 8601 |
|
|
2022
Q4 | $727K | Buy |
120,600
+4,600
| +4% | +$34K | ﹤0.01% | 6924 |
|
|
2022
Q3 | $914K | Sell |
116,000
-82,600
| -42% | -$963K | ﹤0.01% | 6866 |
|
|
2022
Q2 | $2.7M | Buy |
198,600
+77,200
| +64% | +$1.28M | ﹤0.01% | 4270 |
|
|
2022
Q1 | $2.38M | Sell |
121,400
-63,200
| -34% | -$1.26M | ﹤0.01% | 5078 |
|
|
2021
Q4 | $6.33M | Sell |
184,600
-19,200
| -9% | -$772K | ﹤0.01% | 3361 |
|
|
2021
Q3 | $11.1M | Sell |
203,800
-889,000
| -81% | -$53.6M | ﹤0.01% | 2714 |
|
|
2021
Q2 | $80.3M | Buy |
1,092,800
+774,500
| +243% | +$77.4M | 0.01% | 893 |
|
|
2021
Q1 | $29.1M | Buy |
318,300
+188,700
| +146% | +$18.3M | ﹤0.01% | 1502 |
|
|
2020
Q4 | $10.5M | Sell |
129,600
-80,600
| -38% | -$6.17M | ﹤0.01% | 2437 |
|
|
2020
Q3 | $9.79M | Buy |
+210,200
| New | +$11.7M | ﹤0.01% | 2203 |
|
Susquehanna International Group's CVAC Position: Q1 2026 in Review
Susquehanna International Group sold out of CureVac (CVAC) in Q1 2026, closing a stake of 23,604 shares — an estimated $107K sold.
Susquehanna International Group first reported a position in CVAC in Q3 2020 and held it in 20 quarters. The position peaked at $28.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Susquehanna International Group reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 23,604 CureVac shares in Q1 2026, an estimated $107K.
- Susquehanna International Group first reported a position in CureVac in Q3 2020 and held it in 20 quarters.
- Susquehanna International Group's CureVac position peaked at $28.9M in Q1 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.